title: Drug shortages and implications for pediatric patients.
abstract: Drug shortages in the United States continue to be a significant problem that negatively impacts pediatric patients of all ages. These shortages have been associated with a higher rate of relapse among children with cancer, substitution of less effective agents, and greater risk for short- and long-term toxicity. Effective prevention and management of any drug shortage must include considerations for issues specific to pediatric patients; hence, the Pediatric Pharmacy Advocacy Group (PPAG) strongly supports the effective management of shortages by institutions caring for pediatric patients. Recommendations published by groups such as the American Society of Health-System Pharmacists and the American Society for Parenteral and Enteral Nutrition should be incorporated into drug shortage management policies. PPAG also supports the efforts of the Food and Drug Administration (FDA) to not only address but prevent drug shortages caused by manufacturing and quality problems, delays in production, and discontinuations. Prevention, mitigation, and effective management of drug shortages pose significant challenges that require effective communication; hence, PPAG encourages enhanced and early dialogue between the FDA, pharmaceutical manufacturers, professional organizations, and health care institutions.
authors.affiliation: Primary Children's Hospital Intermountain, Salt Lake City, Utah.
authors.forename: Lindsay
authors.initials: L
authors.lastname: Butterfield
authors.affiliation: Primary Children's Hospital Intermountain, Salt Lake City, Utah.
authors.forename: Jared
authors.initials: J
authors.lastname: Cash
authors.affiliation: Children's National Health System, Washington, DC.
authors.forename: Kathy
authors.initials: K
authors.lastname: Pham
keywords: drug shortages